Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells

References

• Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99(20):12617–12621.
   PubMed Web of Science ®Google Scholar
• Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 15(1):79–86.
   PubMed Web of Science ®Google Scholar
• Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S. 2002. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 13(1):40–46.
   PubMedGoogle Scholar
• Chen F, Gerion D. 2004. Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett 4(10):1827–1832.
   Google Scholar
• Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. 2007. Renal clearance of quantum dots. Nat Biotechnol 25(10):1165–1170.
   PubMed Web of Science ®Google Scholar
• Derfus A, Chan W, Bhatia S. 2004. Probing the cytotoxicity of semiconductor nanocrystals. Nano Lett 4(1):11–18.
   PubMed Web of Science ®Google Scholar
• Ernst H, Dungrowth D, Kamilo K, Rittinghausen S, Mohr U. 1996. Nonneoplastic lesions in the lungs. In: Mohr U, Dungrowth D, Capen C, Carlton W, Sundberg J, Ward J, editors. Pathobiology of the aging mouse. Vol. 1. Washington, DC: ILSI Press. pp 281–300.
   Google Scholar
• Esmon CT. 2005. The interactions between inflammation and coagulation. Br J Haematol 131(4):417–430.
   PubMed Web of Science ®Google Scholar
• Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr. 2009. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 18(5):683–692.
   PubMedGoogle Scholar
• Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. 2001. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169(1):12–20.
   PubMedGoogle Scholar
• Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, Nemery B, Hoet PH. 2008. Acute toxicity and prothrombotic effects of quantum dots: Impact of surface charge. Environ Health Perspect 116(12):1607–1613.
   PubMed Web of Science ®Google Scholar
• Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Warbritton AR, Yu WW, Colvin VL, Walker NJ, Howard PC. 2007. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 98(1):249–257.
   PubMedGoogle Scholar
• Han M, Gao X, Su JZ, Nie S. 2001. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 19(7):631–635.
   PubMedGoogle Scholar
• Hardman R. 2006. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114(2):165–172.
   PubMedGoogle Scholar
• Hoet PH, Nemmar A, Nemery B. 2004. Health impact of nanomaterials? Nat Biotechnol 22(1):19.
   PubMedGoogle Scholar
• Hoshino A, Fujioka K, Oku T, Suga M, Sasaki Y, Ohta T, Yasuhara M, Suzuki K, Yamamato K. 2004a. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4(11):2163–2169.
   Google Scholar
• Hoshino A, Hanaki K, Suzuki K, Yamamoto K. 2004b. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem Biophys Res Commun 314(1):46–53.
   PubMedGoogle Scholar
• Hsieh SC, Wang FF, Hung SC, Chen YJ, Wang YJ. 2006. The internalized CdSe/ZnS quantum dots impair the chondrogenesis of bone marrow mesenchymal stem cells. J Biomed Mater Res B Appl Biomater 79(1):95–101.
   PubMedGoogle Scholar
• Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. 2003. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21(1):47–51.
   PubMedGoogle Scholar
• Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22(1):93–97.
   PubMed Web of Science ®Google Scholar
• Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. 2003. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300(5624):1434–1436.
   PubMedGoogle Scholar
• Lin S, Xie X, Patel MR, Yang YH, Li Z, Cao F, Gheysens O, Zhang Y, Gambhir SS, Rao JH, Wu JC. 2007. Quantum dot imaging for embryonic stem cells. BMC Biotechnol 7:67.
   PubMed Web of Science ®Google Scholar
• Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. 2005. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83(5):377–385.
   PubMedGoogle Scholar
• Muller-Borer BJ, Collins MC, Gunst PR, Cascio WE, Kypson AP. 2007. Quantum dot labeling of mesenchymal stem cells. J Nanobiotechnol 5:9.
   PubMedGoogle Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839.
   PubMed Web of Science ®Google Scholar
• Ramot Y, Nyska A. 2007. Drug-induced thrombosis – experimental, clinical, and mechanistic considerations. Toxicol Pathol 35(2):208–225.
   PubMedGoogle Scholar
• Rehm S, Wcislo A, Deerberg F. 1985. Non-neoplastic lesions of female virgin Han:NMRI mice, incidence and influence of food restriction throughout life span. II: Respiratory tract. Lab Anim 19(3):224–235.
   PubMedGoogle Scholar
• Rouse JG, Haslauer CM, Loboa EG, Monteiro-Riviere NA. 2008. Cyclic tensile strain increases interactions between human epidermal keratinocytes and quantum dot nanoparticles. Toxicol In Vitro 22(2):491–497.
   PubMedGoogle Scholar
• Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2007. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 127(1):143–153.
   PubMed Web of Science ®Google Scholar
• Seleverstov O, Zabirnyk O, Zscharnack M, Bulavina L, Nowicki M, Heinrich JM, Yezhelyev M, Emmrich F, O'Regan R, Bader A. 2006. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett 6(12):2826–2832.
   PubMedGoogle Scholar
• Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. 2004. On the cyto-toxicity caused by quantum dots. Microbiol Immunol 48(9):669–675.
   PubMedGoogle Scholar
• Tatara Y, Ohishi M, Yamamoto K, Shiota A, Hayashi N, Iwamoto Y, Takeda M, Takagi T, Katsuya T, Ogihara T, Rakugi H. 2009. Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species. J Mol Cell Cardiol 47(1):104–111.
   PubMedGoogle Scholar
• Voura EB, Jaiswal JK, Mattoussi H, Simon SM. 2004. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 10(9):993–998.
   PubMedGoogle Scholar
• Walker NJ, Bucher JR. 2009. A 21st century paradigm for evaluating the health hazards of nanoscale materials? Toxicol Sci 110(2):251–254.
   PubMedGoogle Scholar
• Yang RS, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, Yeh TK, Yang CS, Lin P. 2007. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 115(9):1339–1343.
   PubMedGoogle Scholar